FOLLOWUS
The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine
- Chinese Journal of Integrative Medicine Vol. 17, Issue 11, Pages: 873-880(2011)
- Affiliations：
1. Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences,Beijing,China
2. Beijing University of Chinese Medicine,Beijing,China
- Author bio：
- Funds：
DOI：10.1007/s11655-011-0796-x
CLC：Published：2011，
Published Online：1 August 2011，
Scan for full text
Yao, Kw., Zhang, Ld. & Wang, J. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine., Chin. J. Integr. Med. 17, 873–880 (2011). https://doi.org/10.1007/s11655-011-0796-x
Kui-wu Yao, Liang-deng Zhang, Jie Wang. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine. [J]. Chinese Journal of Integrative Medicine 17(11):873-880(2011)
Yao, Kw., Zhang, Ld. & Wang, J. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine., Chin. J. Integr. Med. 17, 873–880 (2011). https://doi.org/10.1007/s11655-011-0796-x DOI：
Kui-wu Yao, Liang-deng Zhang, Jie Wang. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine. [J]. Chinese Journal of Integrative Medicine 17(11):873-880(2011) DOI： 10.1007/s11655-011-0796-x.
摘要
Heart failure (HF) is a severe heart disease. The use of autologous bone marrow stem cells (BMCs) mobilization in the treatment of HF has been a hot topic to research both in Western medicine and Chinese medicine (CM). There are many clinical trials and experiments on study of BMCs mobilization for HF therapy
including integrative medicine. The effect of BMCs mobilization is favorable for cardiac repair
while some advantages of CM support the advanced study of its application in BMCs mobilization to treat HF. In addition
with mechanisms of autologous BMCs mobilization for the treatment of HF that will be revealed in the future
especially stem cells niches
integrative medicine would play an important role in this clinical thought of therapy model gradually. Simultaneously
CM should adapt the new approaches of stem cells progresses on HF treatment as holding characteristics of itself.
Abstract
Heart failure (HF) is a severe heart disease. The use of autologous bone marrow stem cells (BMCs) mobilization in the treatment of HF has been a hot topic to research both in Western medicine and Chinese medicine (CM). There are many clinical trials and experiments on study of BMCs mobilization for HF therapy
including integrative medicine. The effect of BMCs mobilization is favorable for cardiac repair
while some advantages of CM support the advanced study of its application in BMCs mobilization to treat HF. In addition
with mechanisms of autologous BMCs mobilization for the treatment of HF that will be revealed in the future
especially stem cells niches
integrative medicine would play an important role in this clinical thought of therapy model gradually. Simultaneously
CM should adapt the new approaches of stem cells progresses on HF treatment as holding characteristics of itself.
关键词
autologous bone marrow stem cells mobilizationheart failureChinese Medicinecardiac repair
Keywords
autologous bone marrow stem cells mobilizationheart failureChinese Medicinecardiac repair
references
Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature 2008;451:919–928.
Strauer BE, Schannwell CM, Brehm M. Therapeutic potentials of stem cells in cardiac diseases. Minerva Cardioangiol 2009;57:249–267.
Davani S, Deschaseaux F, Chalmers D, Tiberghien P, Kantelip JP. Can stem cells mend a broken heart? Cardiovasc Res 2005;65:305–316.
Menown IA, Shand JA. Recent advances in cardiology. Future Cardiol 2010;6:11–17.
Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807–1818.
Chatterjee T, Ortak J, Akin I, Adolph E, Kleinfeldt T, Kische S, et al. Regenerative therapy in cardiology. Praxis (Bern 1994) 2009;98:321–329.
Wei HM, Wong P, Hsu LF, Shim W. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. Singapore Med J 2009;50:935–942.
Guhathakurta S, Subramanyan UR, Balasundari R, Das CK, Madhusankar N, Cherian KM. Stem cell experiments and initial clinical trial of cellular cardiomyoplasty. Asian Cardiovasc Thorac Ann 2009;17:581–586.
Menasché P. Cell therapy: results in cardiology. Bull Acad Natl Med 2009;193:559–569.
Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells 2004;22:487–500.
Akar AR, Durdu S, Cubukçuoğlu Deniz G, Aslan A, Akçali KC, Ozyurda U. Failing heart: remodel, replace or repair? Anadolu Kardiyol Derg 2008;8:148–157.
Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294–2302.
Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSFSTEMI (granulocyte colony-stimulating factor ST-segment elevation myocardial infarction) trial. J Am Coll Cardiol 2006;48:1712–1721.
Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989–997.
Zhang SN, Sun AJ, Ge JB, Yao K, Huang ZY, Wang KQ, et al. Systematic review on safety of intracoronary autologous bone marrow stem cells transfer in patients with acute myocardial infarction. Chin J Cardiol (Chin) 2008;36:679–684.
Zhang SN, Sun AJ, Ge JB, Yao K, Huang ZY, Wang KQ, et al. Effect of intracoronary autologous bone marrow stem cells transfer on left ventricular function after acute myocardial infarction. Chin J Intervent Cardiol 2008:16:317–22.
Yeo C, Mathur A. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regen Med 2009;4:119–127.
Dib N, Taylor DA, Diethrich EB. Stem cell therapy and tissue engineering for cardiovascular repair: from basic research to clinical applications. Singapore: Springer; 2006:42–43.
Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci 2008;38:229–236.
Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT/CXCL2Δ4. Blood 2004;103:110–119.
Chwartz RS, Curfman GD. Can the heart repair itself? N Engl J Med 2002;346:2–5.
Hu YH, Wu HQ, Qi X. Influence of Shenfu Injection on heart function and bone marrow stem cell mobilization in patients with chronic heart failure of coronary heart disease. Chin J Integr Tradit West Med (Chin) 2009;29:309–312.
Qu H, Guo SX, Feng M. Influence of granulocyte colony-stimulating factor to treat 45 cases congestive heart failure. Chin J Misdiagnosis 2005;5:476–477.
Yang QY, Zhao LC. Study on interfere in congestive heart failure after myocardial infarct by Yiqi Wenyang Huoxuefang. Doctorate Dissertation Guangzhou Univ Tradit Chin Med (Chin) 2006:2–48.
Belenkov IuN, Ageev FT, Mareev VIu, Savchenko VG. Mobilization of bone marrow stem cells in the management of patients with heart failure: protocol and first results of ROT FRONT trial. Kardiologiia 2003;43:7–12.
Bocchi EA, Bacal F, Guimarães G, Mendroni A, Mocelin A, Filho AE, et al. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol 2010;138:94–97.
Hüttmann A, Dührsen U, Stypmann J, Noppeney R, Nückel H, Neumann T, et al. Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure-feasibility, safety and effects on exercise tolerance and cardiac function. Basic Res Cardiol 2006;101:78–86.
Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 1996;46:1421–64.
Xing ZL, Ryan MA, Daria D, Nattamai KJ, Zant GV, Wang L, et al. Increased hematopoietic stem cell mobilization in aged mice. Blood 2006;108:2190–2197.
Fazel SS, Chen L, Angoulvant D, Li SH, Weisel RD, Keating A, et al. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB 2008;22:930–940.
Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751–756.
Zhong ZY, Su H, Wang L. Effect of bone marrow stem cells mobilization of Danshen Drip in the therapy of injured heart. Chin J Cardiol (Chin) 2006;34:465.
Aliev G, Shenk JC, Fischbach K, Perry G. Stem cell niches as clinical targets: the future of anti-ischemic therapy? Nat Clin Pract Cardiovasc Med 2008;5:590–591.
Xiao GF, Zhang HQ, Huang XY, Huang WJ, Xu LX. Effects of two ingredients of danshenon number and activity of endothelial progenitor cell in vitro. Chin Archi Tradit Chin Med (Chin) 2006;24:1035.
Chen XF, Tang LJ, Zhu M, Gu ZL, Jiang JJ, Du YX. Effects of tanshinone II A on proliferation, migration and adhesion of endothelial progenitor cells from peripheral blood. Chin Pharmacol Bull (Chin) 2007;23:274.
Ji KT, Zhang HQ, Yang PL, Li HY, Yang DY, Huang XY. Effects of Compound Salvia Injection on number and activity of endothelial progenitor cells. Chin J Chin Mater Med (Chin) 2006;31:246.
Zhang FR, Chen JZ, Zhu JH, Wang XX, Zhu JH, Shang YP, et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Chin J Chin Mater Med (Chin) 2004;29:777.
Wang XX, Shang YP, Chen JZ, Zhu JH, Guo XG, Sun J. Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 2004;39:656.
Liang XW, Liang C, Wu ZG. Effect of TXL and statin on the number and function of peripheral endothelial progenitor cells. Inter J Cardio Dis (Chin) 2007;6:56.
Gu J, Wang CQ, Fan HH, Nie XX, Wang BY, Wang DW. Effects of resveratrol on function of endothelial progenitor cells from peripheral blood. Chin Heart J (Chin) 2006;18:617.
Ji KT, Zhang HQ, Tang JF, Li HY. Effects of danshen on number and activity of endothelial progenitor cells of patients with hypercholesterolemia. Chin J Chin Mater Med (Chin) 2007:32:1214.
Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004;103:1580–1585.
Papayannopoulou T, Scadden DT. Stem-cell ecology and stem cells in motion. Blood 2008;111:3923–3930.
Voog J, Jones DL. Stem cells and the niches: a dynamic duo. Cell Stem Cell 2010;6:103–115.
Scadden DT. The stem-cell niche as an entity of action. Nature 2006;441:1075–1079.
Napoli C, William-Ignarro S, Byrns R, Balestrieri ML, Crimi E, Farzati B, et al. Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 2008;5:571–579.
Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005;106:3020–3027.
Laterveer L, Zijlmans JM, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol 1996;24:1387–1393.
Pruijt JF, Verzaal P, van Os R, de Kruijf EJ, van Schie ML, Mantovani A, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization by interleukin-8 in mice. Proc Natl Acad Sci USA 2002;99:6228–6233.
King AG, Horowitz D, Dillon SB, Levin R, Farese AM, MacVittie TJ, et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 2001;97:1534–1542.
Geissler K, Peschel C, Niederwieser D, Goldschmitt J, Hladik F, Fritz A, et al. Effect of interleukin-3 pretreatment on granulocyte macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells. Br J Haematol 1995;91:299–305.
Postiglione L, Montagnani S, Ladogana P, Castaldo C, Di Spigna G, Bruno EM, et al. Granulocyte Macrophage-Colony Stimulating Factor receptor expression on human cardiomyocytes from end-stage heart failure patients. Eur J Heart Fail 2006;8:564–570.
Nand S, Sosman J, Godwin JE, Fisher RI. A phase I/II study of sequential interleukin-3 and granulocytemacrophage colony-stimulating factor in myelodysplastic syndromes. Blood 1994;83:357–360.
Iwata M, Pillai M, Ramakrishnan A, Hackman RC, Joachim Deeg H, Opdenakker G, et al. Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity. Blood 2007;109:85–92.
Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 2002;99:44–51.
Podar k, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005;105:1383–1395.
Hattori K, Heissig B, Rafii S. The regulation of hematopoietic stem cell progenitor mobilization by chemokines SDF-1. Leuk Lymphoma 2003;44:575–582.
Nakayama BN, Fang I, Elliott G. Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood 1998;91:2283–2295.
Molineux G, McCrea C, Yan XQ, Kerzic P, McNiece I. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 1997;89:3998–4004.
Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, et al. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colonyforming cells and spleen colony-forming units. Blood 1995;85:2747–2755.
National Institutes of Health. National Institutes of Health guidelines on human stem cell research. National Institutes of Health, U.S. Department of Health and Human Services, 2009: http://stemcells.nih.gov/policy/2009guidelines.
Mckay RD, Kooy D, Zwaka TP, Lin HF. Stem cells in 2009. Cell Stem Cell 2009;5:483–489.
0
Views
386
Downloads
1
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
